Can a common MS drug fight brain fog and exhaustion in veterans?
NCT ID NCT07181811
Summary
This study aims to see if taking the MS drug ocrelizumab for a long time helps reduce severe fatigue and improve thinking skills like memory and attention in veterans with multiple sclerosis. Researchers will follow 30 veterans already on this medication for a year, checking their fatigue levels and cognitive performance at the start, 6 months, and 12 months. The goal is to learn if these extra assessments should become part of regular care to better manage MS symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
John D. Dingell VA Medical Center
Detroit, Michigan, 48201, United States
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.